Reusable catheters a safe choice that could save NHS millions, study finds
Reusable catheters are just as safe for patients as single-use ones and do not increase the risk of urinary tract infections, a new study has found. Thousands of… read more.
Reusable catheters are just as safe for patients as single-use ones and do not increase the risk of urinary tract infections, a new study has found. Thousands of… read more.
Current evidence does not support a causal link between the use of almost all antidepressants during pregnancy and an increased risk of neurodevelopmental disorders, including autism and attention-deficit/hyperactivity… read more.
Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, taken during the first trimester of pregnancy are not associated with an increased risk of major birth defects, according… read more.
Osteoporosis, which is highly prevalent in postmenopausal women, has long been associated with an increased risk of fractures. A new study suggests it may also increase a woman’s… read more.
Insomnia is a common problem, affecting as many as 20% to 60% of perimenopausal and postmenopausal US women. Because of its possible severe physical and psychological effects, ongoing… read more.
The Nuffield Department of Women’s & Reproductive Health at the University of Oxford, together with Serac Healthcare Limited announces the publication of Phase 2 data in The Lancet Obstetrics and Gynaecology. The findings highlight the… read more.
Galderma issued new data from two investigator-initiated trials (IITs), demonstrating the power of Sculptra – the first proven regenerative biostimulator – and the company’s versatile hyaluronic acid injectable… read more.
Repeated menstrual cycles may do more than trigger endometriosis. They may rewire the brain. That is the key finding from a new Washington State University study showing that… read more.
A new study suggests that probiotics supplementation during early pregnancy may help reduce the risk of recurrent spontaneous preterm delivery (sPTD). In a multicentre clinical trial, pregnant women… read more.
Cornell University scientists have taken a major step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, considered the holy grail of male contraception. A… read more.
NICE (UK): Fezolinetant can be used as an option to treat moderate to severe vasomotor symptoms associated with menopause when hormone replacement therapy is unsuitable. This recommendation is… read more.
Postmenopausal women face a high risk of bone fractures. Due to declines in estrogen levels, which can lead to an increased risk of osteoporosis, even a low-impact fall… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.